282 related articles for article (PubMed ID: 18362471)
1. Factors associated with survival after surgical resection in Chinese patients with ductal adenocarcinoma of the pancreatic head.
Li Q; Gao C; Li H; Juzi JT; Chen H; Hao X
Dig Surg; 2008; 25(2):87-92. PubMed ID: 18362471
[TBL] [Abstract][Full Text] [Related]
2. [Factors influencing survival of patients with cancer of the pancreatic head after resection].
Gao CT; Li HK; Li Q
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):554-7. PubMed ID: 19950708
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
[TBL] [Abstract][Full Text] [Related]
4. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T
J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
[TBL] [Abstract][Full Text] [Related]
5. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M
Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197
[TBL] [Abstract][Full Text] [Related]
7. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
9. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
Meriggi F; Gramigna P; Forni E
Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
11. Results of a pylorus-preserving pancreatoduodenectomy for pancreatic cancer: a comparison with results of the Whipple procedure.
Takada T; Yasuda H; Amano H; Yoshida M; Ando H
Hepatogastroenterology; 1997; 44(18):1536-40. PubMed ID: 9427018
[TBL] [Abstract][Full Text] [Related]
12. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.
Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y
Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma].
Xie YB; Zhao P; Wang CF; Shan Y; Zhao DB; Liu Q; Bai XF
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):686-9. PubMed ID: 19173911
[TBL] [Abstract][Full Text] [Related]
15. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Berger AC; Watson JC; Ross EA; Hoffman JP
Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
[TBL] [Abstract][Full Text] [Related]
16. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy.
Capussotti L; Massucco P; Ribero D; Viganò L; Muratore A; Calgaro M
Arch Surg; 2003 Dec; 138(12):1316-22. PubMed ID: 14662531
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW
Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768
[TBL] [Abstract][Full Text] [Related]
18. [Results of resection for ductal adenocarcinoma of the pancreatic head].
Morin B; Chiche L; Salame E; Lebreton G; Rouleau V; Segol P
Ann Chir; 2006 Nov; 131(9):518-23. PubMed ID: 17045233
[TBL] [Abstract][Full Text] [Related]
19. Surgical management and outcome in primary adenocarcinoma of the small bowel.
Agrawal S; McCarron EC; Gibbs JF; Nava HR; Wilding GE; Rajput A
Ann Surg Oncol; 2007 Aug; 14(8):2263-9. PubMed ID: 17549572
[TBL] [Abstract][Full Text] [Related]
20. Ductal adenocarcinoma of the pancreas head: survival after regional versus extended lymphadenectomy.
Henne-Bruns D; Vogel I; Lüttges J; Klöppel G; Kremer B
Hepatogastroenterology; 1998; 45(21):855-66. PubMed ID: 9684147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
